Latest News

The innovative medical approach of immunotherapy, harnessing the body's immune system to fight diseases like cancer more effectively. Abstract concept. | Image Credit: © TensorSpark - © TensorSpark - stock.adobe.com
Nxera and Cancer Research UK Advance Oral EP4 Antagonist into Phase IIa Study

September 17th 2025

The Phase IIa trial will further explore the EP4 antagonist HTL0039732 in combination with immunotherapy to improve outcomes in resistant solid tumors and expand treatment options.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
CSL Backs Late-Stage Development of VarmX’s Coagulation Therapy VMX-C001X

September 16th 2025

Background with viruses. Adeno-associated virus serotype 1. Virus is used as a vector for gene therapy. A model is built using data of viral macromolecular structure from Protein Data Bank (PDB 3NG9) | Image Credit: © Dr_Microbe - © Dr_Microbe - stock.adobe.com
AAV Manufacturing Partnership Supports Gene Therapy for CLN2 Batten Disease

September 4th 2025

Ribosome translating mRNA into a polypeptide chain | Image Credit: © Juan Gärtner - © Juan Gärtner - stock.adobe.com
Quotient Sciences and CPI Target Faster RNA-Based Drug Development

September 3rd 2025

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com
What the Aptamer-Invizius H-Guard Immune Modulation Collab Means for Biopharma

September 3rd 2025

Taking Full Advantage of Service Providers

There are considerations companies may want to consider before seeking out a service provider.

Taking Full Advantage of Service Providers; Image: Gorodenkoff - stock.adobe.com

More News

© 2025 MJH Life Sciences

All rights reserved.